Weight Loss Stacks
Peptide combinations for fat loss, appetite management, and body recomposition. Multi-pathway approaches targeting metabolism, hunger signaling, and fat mobilization.
Powerful appetite suppression via GLP-1 combined with visceral fat targeting through GHRH. Comprehensive approach to stubborn body fat.
GLP-1 appetite control paired with HGH fragment for fat metabolism. AOD-9604 targets lipolysis without GH-related side effects.
Dual GLP-1/GIP agonist protocol. Often used standalone due to potency. Detailed titration schedule and management strategies.
Fat loss with muscle preservation. GLP-1 for caloric reduction plus GH optimization to maintain lean mass during deficit.
Weight Loss Stack Principles
Effective weight loss stacks typically combine compounds that address different aspects of the fat loss equation:
Common mechanisms targeted:
- Appetite suppression (GLP-1 agonists) - Reduce caloric intake through satiety signaling
- Fat mobilization (AOD-9604, HGH frag) - Enhance lipolysis and fatty acid release
- Visceral fat targeting (Tesamorelin) - Specifically reduce dangerous abdominal fat
- Metabolic support (GH peptides) - Maintain muscle mass and metabolic rate
Important considerations:
- GLP-1 agonists require careful titration to manage GI side effects
- Rapid weight loss without GH support can result in muscle loss
- Nutrition and exercise remain foundational - peptides enhance, not replace
- Some compounds (Semaglutide, Tirzepatide) are FDA-approved for obesity